Skip to main content

Table 2 Sex-specific distribution of breast lesions diagnosed by breast cytology

From: Cytological evaluation of breast lesions in symptomatic patients presenting to Kenyatta National Hospital, Kenya: a retrospective study

Cytological diagnoses

Women

Men

Total

n (%)

n (%)

n (%)

A. Neoplastic

 

Ductal carcinoma

63 (18 %)

5 (12.5 %)

68 (17.4 %)

Fibroadenoma

136 (38.9 %)

0 (0 %)

136 (34.9 %)

Fibrocystic changes

38 (10.9 %)

0 (0 %)

38 (9.7 %)

Benign breast lesion, NOS

19 (5.4 %)

1 (2.5 %)

20 (5.1 %)

Intraductal papilloma

12 (3.4 %)

0 (0 %)

12 (3.1 %)

Lobular carcinoma

6 (1.7 %)

0 (0 %)

6 (1.5 %)

Malignant breast lesion

5 (1.4 %)

0 (0 %)

5 (1.3 %)

Suspicious for malignancy

3 (0.9 %)

0 (0 %)

3 (0.8 %)

Fibroadenomatosis

2 (0.6 %)

0 (0 %)

2 (0.5 %)

Intraductal papilloma with fibrocystic changes

2 (0.6 %)

0 (0 %)

2 (0.5 %)

Fibroadenoma with granulomatous mastitis

1 (0.3 %)

0 (0 %)

1 (0.3 %)

Ductal hyperplasia

1 (0.3 %)

0 (0 %)

1 (0.3 %)

Benign breast lesion with atypia

1 (0.3 %)

0 (0 %)

1 (0.3 %)

Benign proliferative breast disease

1 (0.3 %)

0 (0 %)

1 (0.3 %)

B. Non-neoplastic

 

Gynecomastia

0 (0 %)

33 (82.5 %)

33 (8.5 %)

Galactocele

12 (3.4 %)

0 (0 %)

12 (3.1 %)

Fat necrosis

12 (3.4 %)

0 (0 %)

12 (3.1 %)

Breast abscess

9 (2.6 %)

0 (0 %)

9 (2.3 %)

Inflammatory breast lesion

9 (2.6 %)

1 (2.5 %)

10 (2.6 %)

Mammary duct ectasia

8 (2.3 %)

0 (0 %)

8 (2.1 %)

Acute mastitis

3 (0.9 %)

0 (0 %)

3 (0.8 %)

Cystic breast mass

3 (0.9 %)

0 (0 %)

3 (0.8 %)

Granulomatous mastitis

3 (0.9 %)

0 (0 %)

3 (0.8 %)

Breast ulcer

1 (0.3 %)

0 (0 %)

1 (0.3 %)